Prediction of relapse in hyperthyroid Graves' disease
- PMID: 6103438
- DOI: 10.1016/s0140-6736(80)91551-2
Prediction of relapse in hyperthyroid Graves' disease
Abstract
Within a year of stopping a 6-month course of carbimazole treatment 41 of 65 patients (63%) with hyperthyroid Graves' disease had a recurrence of their hyperthyroidism. By combined analysis of the HLA-DRw3 status and the level of thyrotrophin-receptor antibody at the time of drug withdrawal relapse or remission could be predicted in 62 of the 65 patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
